Polygen (PGEN) news

Updated Version 4 - The US Food and Drug Administration (FDA) has approved Inovio's drug for treating a rare throat disease; the company's stock price soared.

Update Version 3 - The US Food and Drug Administration (FDA) has approved Inovio’s drug to treat a rare throat disease; the company's stock price soared.

US Stock Market Movement: Precigen surged on September 30th due to FDA platform approval and Papzimeos volume increase

PRECIGEN, INC. : B. RILEY INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $12